A Link Quality Prediction Metric for Location based Routing Protocols under Shadowing and Fading Effects in Vehicular Ad Hoc Networks

AbstractThe location-based routing protocol has been chosen as one of the efficient routing approaches in vehicular ad hoc networks in terms of low overhead and high scalability. Its critical advantage lies in performing a pathless routing such that a node having a packet forwards it to its neighbor node that provides the shortest physical distance to destination and this process continues until the packet reaches destination. The problem lies in that the link stability of the neighbors varies largely depending on the mobility of vehicles and the environmental factors that incur shadowing and fading effects. In this paper, we propose a new link quality prediction metric associated with location based protocols to improve the selection of next hop, that consider both the link quality assessment based on the transmission success rate and the link quality assessment based on the prediction of the future locations of vehicles. Simulation results are presented to demonstrate the efficiency of the proposed metric

Development of low-grade waste heat recovery using lead-free pyroelectric Ba(Zr,Ti)O3

国立大学法人長岡技術科学大学博士（工学）Articledoctoral thesi

PURIFICATION OF PHOSPHOGYPSUM FOR USE AS CEMENT RETARDER BY SULPHURIC ACID TREATMENT

Phosphogypsum is a by-product of the wet phosphoric acid production. In this study, chemical compositions of phosphogypsum waste (PG) in Hai Phong diammonium phosphate plant (DAP1) and Lao Cai diammonium phosphate plant (DAP2) in Vietnam were surveyed for the purpose of gypsum recovery by P2O5, F removal to meet TCVN11833 for use treated gypsum as cement retarder. Studies of impurities P2O5, F, TOC removal by sulfuric acid 10 % at 28 0C was presented. The results found that the combination of a low concentration of sulfuric acid treatment, washing, lime neutralizing, and thermal treatment was successful in Phoshogypsum treatment for use as cement retarder. The cement test proved that treated PG could partially replace natural gypsum as a retarder.Keywords:  phosphogypsum treatment, phosphorus pentoxide removal, calcium sulfate transition phase, cement retarder.

Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial

Background Trials of fluoxetine for recovery after stroke report conflicting results. The Assessment oF FluoxetINe In sTroke recoverY (AFFINITY) trial aimed to show if daily oral fluoxetine for 6 months after stroke improves functional outcome in an ethnically diverse population. Methods AFFINITY was a randomised, parallel-group, double-blind, placebo-controlled trial done in 43 hospital stroke units in Australia (n=29), New Zealand (four), and Vietnam (ten). Eligible patients were adults (aged ≥18 years) with a clinical diagnosis of acute stroke in the previous 2–15 days, brain imaging consistent with ischaemic or haemorrhagic stroke, and a persisting neurological deficit that produced a modified Rankin Scale (mRS) score of 1 or more. Patients were randomly assigned 1:1 via a web-based system using a minimisation algorithm to once daily, oral fluoxetine 20 mg capsules or matching placebo for 6 months. Patients, carers, investigators, and outcome assessors were masked to the treatment allocation. The primary outcome was functional status, measured by the mRS, at 6 months. The primary analysis was an ordinal logistic regression of the mRS at 6 months, adjusted for minimisation variables. Primary and safety analyses were done according to the patient's treatment allocation. The trial is registered with the Australian New Zealand Clinical Trials Registry, ACTRN12611000774921. Findings Between Jan 11, 2013, and June 30, 2019, 1280 patients were recruited in Australia (n=532), New Zealand (n=42), and Vietnam (n=706), of whom 642 were randomly assigned to fluoxetine and 638 were randomly assigned to placebo. Mean duration of trial treatment was 167 days (SD 48·1). At 6 months, mRS data were available in 624 (97%) patients in the fluoxetine group and 632 (99%) in the placebo group. The distribution of mRS categories was similar in the fluoxetine and placebo groups (adjusted common odds ratio 0·94, 95% CI 0·76–1·15; p=0·53). Compared with patients in the placebo group, patients in the fluoxetine group had more falls (20 [3%] vs seven [1%]; p=0·018), bone fractures (19 [3%] vs six [1%]; p=0·014), and epileptic seizures (ten [2%] vs two [<1%]; p=0·038) at 6 months. Interpretation Oral fluoxetine 20 mg daily for 6 months after acute stroke did not improve functional outcome and increased the risk of falls, bone fractures, and epileptic seizures. These results do not support the use of fluoxetine to improve functional outcome after stroke

The Aspect Oriented Markup Language and Its Support of Aspect Plugins

We describe the Aspect Markup Language (AML), an XML-based AOP language for programming aspects. AML separates the binding instructions, written in XML, from the executable aspect code, written in a regular programming language. This separation by itself has some advantages, namely for testing. But the main goal of AML is to provide a highly extensible AOP platform, with which programmers can easily define their own constructs using well-known plugin techniques. This novel feature enables the development of AOP toolkits that target domain-specific crosscutting concerns